Icon

KAPVAY (nda022331)- (0.1MG,0.2MG)

CLONIDINE HYDROCHLORIDE CONCORDIA PHARMS INC
0.1MG,0.2MG
Yes Yes
2013-Oct-13 Expired
None 2013-Sep-28
None No
KAPVAY ® is a centrally acting alpha2-adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.
10 0 7
Total Other Developers 3
Drugs with Suitability No
0.1MG ** ** - - 5
0.2MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ********* ******* ********* *** *********** *** ****** ***, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ********* ** ***** ******* *********** ****-*, **** **. ***, ***, ****** - **, ******* ******** ****, *****, ******, *********** ******, ***** (***) ***
****** ****** **** ****** ************ ***. *********** * ********* ****, **** ***** ****, *****, *******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***
****** ****** ** ***** ** ****** ** ************** **., ***. *********** **** ******** **** ****, ******, ****** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.